Publication Name	World Journal of Transplantation
Manuscript ID	21815
Country	Canada

Received	2015-07-30 09:12
Peer-Review Started	2015-07-31 10:52
To Make the First Decision	2015-10-27 11:01
Return for Revision	2015-11-06 16:36
Revised	2015-11-26 00:06
Second Decision	2016-02-02 11:07
Accepted by Journal Editor-in-Chief	2016-02-03 19:54
Accepted by Company Editor-in-Chief	2016-02-17 15:06
Articles in Press	2016-02-17 15:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-02-21 14:07
Publish the Manuscript Online	2016-03-18 14:28

ISSN	2220-3230 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Review
Article Title	Post-transplant dyslipidemia: Mechanisms, diagnosis and management
Manuscript Source	Invited Manuscript
All Author List	Arnav Agarwal and G V Ramesh Prasad
Funding Agency and Grant Number
Corresponding Author	G V Ramesh Prasad, MBBS, MSc, MA, FRCPC, FACP, FASN, Division of Nephrology, Department of Medicine, University of Toronto, 61 Queen Street East, 9th Floor, Toronto, ON M5C 2T2, Canada. prasadr@smh.ca
Key Words	Cholesterol; Dyslipidemia; Triglycerides; Statins; Immunosuppression
Core Tip	Post-transplant dyslipidemia is highly prevalent in all solid organ transplant recipient populations. Guidelines for therapy are derived mostly from general population experiences, although the mechanisms for dyslipidemia due to immunosuppression are distinct and known. Statin therapy has understandably received the most attention in transplant populations but the potential efficacy of other therapeutic strategies should not be ignored.
Publish Date	2016-03-18 14:28
Citation	Agarwal A, Prasad GVR. Post-transplant dyslipidemia: Mecha­nisms, diagnosis and management. World J Transplant 2016; 6(1): 125-134
URL	http://www.wjgnet.com/2220-3230/full/v6/i1/125.htm
DOI	http://dx.doi.org/10.5500/wjt.v6.i1.125

Full Article (PDF)	WJT-6-125.pdf
Full Article (Word)	WJT-6-125.doc
Manuscript File	21815-Review.docx
Answering Reviewers	21815-Answering reviewers.pdf
Audio Core Tip	21815-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	21815-Conflict-of-interest statement.pdf
Copyright License Agreement	21815-Copyright assignment.pdf
Peer-review Report	21815-Peer-review(s).pdf
Scientific Misconduct Check	21815-Scientific misconduct check.pdf
Scientific Editor Work List	21815-Scientific editor work list.pdf